AZ CHINOOK D3250C00059 A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics
Administered By
Awarded By
Contributors
- Oberle, Amber Janelle Principal Investigator
Start/End
- September 5, 2019 - February 14, 2023